Kristin M. Roshelli

Kristin Roshelli focuses on corporate and regulatory matters in the healthcare and life sciences industries.  She represents a broad range of prominent healthcare and life sciences clients on mergers and acquisitions, affiliations, general health law questions, and complex corporate governance and contracting matters. She has extensive experience structuring and negotiating transactions, particularly as to complex arrangements involving health systems, physician practices, and academic medical centers.  Kristin has helped establish the legal and operational framework in connection with the startup of three new medical schools and multiple new health systems.  Kristin also assists healthcare and life sciences companies with regulatory reviews, internal investigations, and transaction-related diligence.  She is also a go-to lawyer for leading pharmaceutical and biotech companies and organ procurement organizations for assistance with complex collaboration arrangements with third parties and in establishing and negotiating their supply chain and other key contracts.  Her work often involves advising on national and cross-border licensing arrangements, product manufacturing agreements, development agreements, commercialization arrangements, distribution services agreements, specialty pharmacy agreements, and other complex collaboration arrangements and key service and supply contracts.  She also advises in matters involving research, such as the creation of collaborative research arrangements and contract matters relating to clinical trial agreements.

She is Chambers-ranked for healthcare in Texas and has been recognized by Legal 500 and Texas Super Lawyers.  Prior to entering the legal field, Kristin served as a nurse in the United States Air Force, worked in the general counsel’s office of a large academic medical center, and practiced as a registered nurse in a medical intensive care unit. 

Publications

• 2016 Health Care Fraud and Abuse Top Ten List Reimbursement Advisor, Vol 32, No. 6, February 2017
• “The Plot Thickens for the Medicare Narrative Requirement,” Law360, February 2015
• “When is a Hospital a ‘New Hospital?,’” Reimbursement Advisor, Vol. 30, No. 4, December 2014